Microcap Ledger

Tickers · $GYRO

Gyrodyne, LLC $GYRO

By Microcap Ledger desk · CIK 0001589061

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Opeators of Nonresidential Buildings
Headquarters
St. James, NY
Fiscal year end
December 31
Shares outstanding
2,199,308 [10-Q 2026-08-13]
as of 2026-08-13

Sources: [10-K 2026-03-27]

What the company doesAI summary of filing

Gyrodyne, LLC is a real estate company that owns and manages a portfolio of medical office and industrial properties located in Suffolk County (Flowerfield in St. James) and Westchester County (Cortlandt Manor) in New York. The company generates revenue through long-term leases on these properties, with tenants typically reimbursing the company for utilities, insurance, repairs, maintenance, and real estate taxes. Gyrodyne is pursuing entitlements and zoning approvals on both properties to increase their development flexibility and value, with the goal of selling all real estate assets and liquidating the company by the end of 2028, after which it will distribute remaining proceeds to shareholders. The company is currently revenue-generating but operating under a planned liquidation strategy. [10-K 2026-03-27]

Segments: Flowerfield (St. James, NY) - Industrial/Medical Office, Cortlandt Manor (Cortlandt Manor, NY) - Medical Office

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
8 months to Aug 2015$1.83M−$2.50M −$2.29M$7.47M[10-K 2016-03-30]
FY ended Dec 2014$2.80M−$3.11M −$5.47M$4.03M[10-K 2016-03-30]
Quarterly cash burn
−$860.2K
Cash runway Estimate
~26 months

Estimate: cash at the end of the period (8 months to Aug 2015) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-192,199,308[10-Q 2024-11-19]
2025-03-282,199,308[10-K 2025-03-28]
2025-05-052,199,308[10-Q 2025-05-05]
2025-08-082,199,308[10-Q 2025-08-08]
2025-11-102,199,308[10-Q 2025-11-10]
2026-03-302,199,308[10-K 2026-03-27]
2026-05-132,199,308[10-Q 2026-05-13]
2026-08-132,199,308[10-Q 2026-08-13]
Shelf registration
S-1 filed 2023-12-29; declared effective 2024-02-02 [S-1 2023-12-29]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-10-05DEF 14AProxy statement
2026-08-1310-QQuarterly report
2026-08-078-KDirector or officer change
2026-05-1310-QQuarterly report
2026-03-2710-KAnnual report
2026-01-128-KMaterial agreement entered
2025-11-1010-QQuarterly report
2025-11-078-KShareholder vote results
2025-11-058-KRegulation FD disclosure
2025-10-2013D/ABeneficial ownership report (5%+ holder)
2025-10-17DEF 14AProxy statement
2025-10-178-KMaterial agreement entered; Other events

Facts as of . Small caps move fast; check the latest filings.